Top Markets
Coin of the day
Histogen Inc. Histogen Inc.

Histogen Inc.

HSTO
株式のランク #40869
Histogen Inc. operates as a clinical-stage biotechnology company, focusing on... Histogen Inc. operates as a clinical-stage biotechnology company, focusing on the development of novel, stem cell-free biologic products derived from its proprietary hypoxia-generated growth factor technology platform. Among its offerings is HST-003, a human extracellular matrix, currently undergoing Phase 1/2 clinical trials to mend articular cartilage defects in the knee. Additionally, the company is advancing HST-004, a cell-conditioned media solution designed for spinal disc repair, and Emricasan, an orally active pan-caspase inhibitor targeting COVID-19 treatment. In its preclinical pipeline, Histogen is developing CTS-2090 and CTS-2096. These are selective caspase-1 inhibitors formulated to suppress inflammasome activation and intervene in a range of inflammation-mediated conditions. Founded in 2007, Histogen Inc. maintains its headquarters in San Diego, California.
株価
$0.02765
最終同期: 2024-12-23
時価総額
$69.04K
変化(1日)
0.00%
変化(1年)
0.00%
US
取引 Histogen Inc. (HSTO)

カテゴリー

Histogen Inc.(HSTO)の株価履歴
終値の最高値: $0.02 (2024-12-01)

終値の最安値: $186.88 (2013-07-01)
Histogen Inc. の株価履歴(2013 ~ 2026)
年間株価パフォーマンス
パフォーマンス
2024 -28.82%
2023 -66.41%
2022 -88.05%
2021 -66.17%
2020 -68.37%
2019 -78.98%
2018 -59.92%
2017 45.54%
2016 4.61%
2015 -61.12%
2014 15.35%
2013 0.00%
類似企業または競合の株価
企業 株価 変化率 1年%
$517.18 30.63%
US
$857.76 32.66%
NL
$744.96 8.94%
CH
$1.08K -6.68%
KR
$259.89 16.65%
BE